Citation Impact
Citing Papers
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
2003 Standout
Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly
1991
Activated persulfate for organic chemical degradation: A review
2016 Standout
The influence of drug-like concepts on decision-making in medicinal chemistry
2007 Standout
Syndemics and the biosocial conception of health
2017 Standout
Novel Oral Drug Formulations
1994
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Clinical development and potential of photothermal and photodynamic therapies for cancer
2020 Standout
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
2002
Acute and chronic arsenic toxicity
2003 Standout
Laser-photosensitizer assisted immunotherapy: a novel modality for cancer treatment
1997
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
Antipyrine as a probe for human oxidative drug metabolism: Identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation*
1996
Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications
2003 Standout
Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?
2004 Standout
Exercise training and oxidative stress in the elderly as measured by antipyrine hydroxylation products
2001
Influence of Diet and Nutritional Status on Drug Metabolism
1996
Designing hydrogels for controlled drug delivery
2016 Standout
Zopiclone, but not brotizolam, impairs memory storage during sleep
2003
Enzyme induction in the cytochrome P-450 system
1990 Standout
Herb-Drug Interactions
2005 Standout
Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials
2003 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Antipyrine as a model drug to study hepatic drug-metabolizing capacity
1988
Psychopharmacologic Treatment of Depression in the Medically Ill
1998
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly
1991
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
Property-Based Design: Optimization of Drug Absorption and Pharmacokinetics
2001
Accelerated improvement of alcoholic liver disease with enteral nutrition
1992
Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients
1993 Standout
Calculated Absorption and Scattering Properties of Gold Nanoparticles of Different Size, Shape, and Composition: Applications in Biological Imaging and Biomedicine
2006 Standout
Primary Biliary Cirrhosis
1987 Standout
Genetic variation in rates of antipyrine metabolite formation: a study in uninduced twins.
1981
Primary Biliary Cirrhosis
2011 Standout
Goodman & Gilman's The Pharmacological Basis of Therapeutics
1985 Standout
Desymmetrization‐like Catalytic Enantioselective Fluorination of Malonates and Its Application to Pharmaceutically Attractive Molecules
2007
About Sleep's Role in Memory
2013 Standout
Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis
1985
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
Clinical Implications of Enzyme Induction and Enzyme Inhibition
1981
Kinetic oxidation of antipyrine in heat-activated persulfate
2013
Genetically Determined Variability in Acetylation and Oxidation Therapeutic Implications
1985
The effect of age upon liver volume and apparent liver blood flow in healthy man
1989
Chitin and Chitosan Preparation from Marine Sources. Structure, Properties and Applications
2015 Standout
Pharmacogenetic Determinants of Codeine Induction by Rifampin: The Impact on Codeine’s Respiratory, Psychomotor and Miotic Effects
1997
Human cytochromes P-450
1984
Works of DD Breimer being referenced
Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.
1991
Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.
1984
Antipyrine metabolite formation in children in the acute phase of malnutrition and after recovery.
1980
Influence of rifampicin treatment on antipyrine clearance and metabolite formation in patients with tuberculosis.
1984
Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers.
1979
Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a ‘cocktail’ approach.
1988
Stereoselective pharmacokinetics of oral and intravenous nitrendipine in healthy male subjects.
1991
Assay of Antipyrine and Its Primary Metabolites in Plasma, Saliva and Urine by High-Performance Liquid Chromatography and Some Preliminary Results in Man
1979
Oral absorption profile of nitrendipine in healthy subjects: a kinetic and dynamic study.
1989
Stereoselectivity in the urinary excretion of the mercapturates of (R‐) and (S‐) alpha‐bromoisovalerylurea in man.
1989
The disposition of antipyrine and its metabolites in young and elderly healthy volunteers.
1987
Pharmacokinetics of brotizolam in healthy subjects following intravenous and oral administration.
1983
Relationship between mephenytoin oxidation polymorphism and phenytoin, methylphenytoin and phenobarbitone hydroxylation assessed in a phenotyped panel of healthy subjects.
1990
Effect of age and liver cirrhosis on the pharmacokinetics of nitrazepam.
1983
Differential effects of enzyme induction on antipyrine metabolite formation.
1982
Pharmacokinetics of brotizolam in the elderly.
1983